New Haven, CT · Founded 2018 · Privately Held (backing)
Developer of a therapeutic drug designed to reverse neurodegeneration. Allyx Therapeutics is based in New Haven, CT and was founded in 2018. Its last reported valuation was $32.3 million in Feb 2023. It has raised $13.2 million across 4 recorded rounds; the latest was a $26.4 million early-stage round in May 2026.
Last reported valuation
$32.3M
Oct 2026
Priced at
—
Total raised
$13.2M
Last round
Early Stage VC
May 2026
Team — not yet on record
No current team members for Allyx Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Allyx Therapeutics with a free account
·Watch Allyx Therapeutics: the Monday email on marks, rounds and moves
